Cell-free nucleic acid fragmentomics: A non-invasive window into cellular epigenomes
Translational Oncology · 2024-11 · 49 · 102085
DOI: 10.1016/j.tranon.2024.102085 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Translational Oncology, 2024-11. Verfasst von Ahmad Salman Sirajee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Rutgers Cancer Institute, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA.…. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, New Jersey Department of Health, NIH.
Abstract (Originalsprache)
Clinical genomic profiling of cell-free nucleic acids (e.g. cell-free DNA or cfDNA) from blood and other body fluids has ushered in a new era in non-invasive diagnostics and treatment monitoring strategies for health conditions and diseases such as cancer. Genomic analysis of cfDNAs not only identifies disease-associated mutations, but emerging findings suggest that structural, topological, and fragmentation characteristics of cfDNAs reveal crucial information about the location of source tissues, their epigenomes, and other clinically relevant characteristics, leading to the burgeoning field of fragmentomics. The field has seen rapid developments in computational and genomics methodologies for conducting large-scale studies on health conditions and diseases - that have led to fundamental, mechanistic discoveries as well as translational applications. Several recent studies have shown the clinical utilities of the cfDNA fragmentomics technique which has the potential to be effective for early disease diagnosis, determining treatment outcomes, and risk-free continuous patient monitoring in a non-invasive manner. In this article, we outline recent developments in computational genomic methodologies and analysis strategies, as well as the emerging insights from cfNA fragmentomics. We conclude by highlighting the current challenges and opportunities.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, Rutgers Cancer Institute, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA. Electronic address: as4184@scarletmail.rutgers.edu.
- Department of Pathology and Laboratory Medicine, Rutgers Cancer Institute, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA.
- Department of Pathology and Laboratory Medicine, Rutgers Cancer Institute, Rutgers, The State University of New Jersey, New Brunswick, NJ 08901, USA. Electronic address: subhajyoti.de@rutgers.edu.
Förderung
- NIGMS NIH HHS
- New Jersey Department of Health
- NIH
Zitieren
APA
Sirajee, A. S., Kabiraj, D., & De, S. (2024). Cell-free nucleic acid fragmentomics: A non-invasive window into cellular epigenomes. Translational Oncology, 49, 102085. https://doi.org/10.1016/j.tranon.2024.102085
Vancouver
Sirajee AS, Kabiraj D, De S. Cell-free nucleic acid fragmentomics: A non-invasive window into cellular epigenomes. Translational Oncology. 2024;49:102085. doi:10.1016/j.tranon.2024.102085
BibTeX
@article{Sirajee2024,
author = {Sirajee, Ahmad Salman and Kabiraj, Debajyoti and De, Subhajyoti},
title = {Cell-free nucleic acid fragmentomics: A non-invasive window into cellular epigenomes},
journal = {Translational Oncology},
year = {2024},
volume = {49},
pages = {102085},
doi = {10.1016/j.tranon.2024.102085}
}
EUVIMED